Type IV glycogenosis. Report of a case proven by characterization of glycogen and studied at necropsy
- PMID: 13988891
Item in Clipboard
Type IV glycogenosis. Report of a case proven by characterization of glycogen and studied at necropsy
Bull Johns Hopkins Hosp.
1962 Sep.
No abstract available
Similar articles
-
Glycogen storage disease (Type IV): a familial cirrhosis diagnosed by electron microscopy (case report).Indian Pediatr. 1980 Jul;17(7):625-7. Indian Pediatr. 1980. PMID: 6938485 No abstract available.
-
[Recognition of glycogenosis Type IV (amylopectinosis). Ultrastructural studies in 3 brothers with juvenile liver cirrhosis].Verh Dtsch Ges Pathol. 1978;62:531. Verh Dtsch Ges Pathol. 1978. PMID: 284673 German. No abstract available.
-
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase.Lab Invest. 1968 Nov;19(5):546-57. Lab Invest. 1968. PMID: 5247008 No abstract available.
-
[Glycogenosis of type 3 A and liver cirrhosis].Pediatrie. 1971 Jul-Aug;26(5):571-2. Pediatrie. 1971. PMID: 5284429 French. No abstract available.
-
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.Semin Pediatr Neurol. 2006 Jun;13(2):115-20. doi: 10.1016/j.spen.2006.06.007. Semin Pediatr Neurol. 2006. PMID: 17027861 Review.
Cited by
-
Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis.Proc Natl Acad Sci U S A. 1966 Aug;56(2):725-9. doi: 10.1073/pnas.56.2.725. Proc Natl Acad Sci U S A. 1966. PMID: 5229990 Free PMC article. No abstract available.
-
Glycogen storage disease type IV, amylopectinosis.Arch Dis Child. 1968 Oct;43(231):548-55. doi: 10.1136/adc.43.231.548. Arch Dis Child. 1968. PMID: 5246692 Free PMC article. No abstract available.
-
A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.Front Genet. 2022 Sep 13;13:992406. doi: 10.3389/fgene.2022.992406. eCollection 2022. Front Genet. 2022. PMID: 36176296 Free PMC article.
-
Synthesis, characterization, and X-ray attenuation properties of ultrasmall BiOI nanoparticles: toward renal clearable particulate CT contrast agents.Inorg Chem. 2014 Oct 6;53(19):10189-94. doi: 10.1021/ic5011709. Epub 2014 Sep 9. Inorg Chem. 2014. PMID: 25283335 Free PMC article.
-
INHERITED ENZYME DEFECTS: A REVIEW.J Clin Pathol. 1963 Jul;16(4):293-318. doi: 10.1136/jcp.16.4.293. J Clin Pathol. 1963. PMID: 14044031 Free PMC article. Review. No abstract available.